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Maternal smoking and micronutrient intake during pregnancy are two strong 
biological candidates for impacting the developing epigenome. The extent to which 
DNA methylation in offspring is modified by these intrauterine exposures has not 
been presented in parallel. In this review, we summarize human studies which have 
investigated genome-wide DNA methylation in the offspring in relation to maternal 
smoking and one-carbon micronutrient exposure during pregnancy. We contrast the 
primarily independent efforts for these two categories of exposure, and potential 
explanations for these differences. We emphasize methodological considerations 
such as power to detect methylation signals, exposure assessment, control of sources 
of variability, causal inference and the role of observed methylation changes in 
mediating downstream outcomes in the offspring.
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DNA methylation profiling is the most widely 
used technique to evaluate the impact of early 
life exposures on the newborn’s epigenome. 
With the advent of the Illumina Infinium 
Methyl450 Beadchip (450K) [1], research-
ers can evaluate CpG-specific DNA meth-
ylation differences at sites spread across the 
epigenome in large epidemiological studies. 
After the initial flood of research to apply this 
technology in epigenetic epidemiology, with 
a focus on performing epigenome-wide asso-
ciation studies (EWAS), the dust has begun 
to settle on the field for some important 
 exposures  considered in human studies.
We review two categories of exposures 
that have been considered strong biologi-
cal candidates for impacting the developing 
epigenome: maternal smoking during preg-
nancy and maternal one-carbon micronutri-
ent exposures during pregnancy. The extent 
to which DNA methylation in offspring 
is modified by maternal periconceptional 
micronutrients compared with smoking 
exposures has not been presented in paral-
lel. In this review, we focus on human stud-
ies measuring these exposures for the mother 
during pregnancy and the genome-wide 
CpG-specific DNA methylation in newborns 
or children of these mothers (related to expo-
sure). We contrast the primarily independent 
epigenomic efforts for these two exposures, 
address research needs and suggest potential 
future directions.
Exposures of interest
Maternal smoking
Cigarette smoke, as well as being a known 
carcinogen which has detrimental health 
consequences for smokers, is a well-estab-
lished toxicant associated with many health 
effects in the offspring of those exposed 
in utero, including both adverse birth out-
comes and later life health outcomes [2]. 
Smoke exposure has a profound effect on 
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epigenetic profiles and genome-wide DNA meth-
ylation changes have been identified in response to 
both personal smoking and perinatal exposure [3]. 
Alterations in DNA methylation are one possible 
mechanism mediating the harmful effects of smoke 
exposure, and both candidate gene [4] and EWAS [5] 
have identified methylation changes in gene regions 
involved in the etiology of smoking-relating out-
comes. In many respects, the investigation of meth-
ylation changes related to prenatal smoke exposure 
represents a ‘flagship’ exposition of epigenome-wide 
approaches for investigating maternal exposures, with 
an increasing number of methylation signatures in 
regions of the genome being consistently replicated 
between studies.
Maternal one-carbon micronutrients
Micronutrients are essential nutrients that play a cru-
cial role in fetal development, most notably by the 
prevention of neural tube defects in newborns by 
maternal folic acid supplementation before and early 
in pregnancy. Severe deficiencies in micronutrients 
such as folate, iron, zinc and various vitamins can lead 
to adverse pregnancy outcomes, particularly in under-
nourished populations [6]. Micronutrients particu-
larly relevant to epigenetic mechanisms include those 
involved in the one-carbon metabolism pathway [7], 
including folate, choline, betaine and other B vita-
mins. The one-carbon metabolism pathway provides 
methyl groups for a range of biochemical reactions 
including methylation of DNA which impacts gene 
expression. Differences in genome-wide DNA meth-
ylation in newborns has been evaluated in relation to 
maternal folate and other micronutrient exposures in 
candidate gene methylation studies [8] and EWAS [5], 
where folate is the predominant nutrient showing sig-
nificant associations with the developing epigenome. 
Comparison of effects in nourished versus undernour-
ished populations remains to be fully elucidated as 
well as the extent to which single micronutrients or 
combinations of micronutrients impact methylation 
differences. Given the relevance to the epigenome, 
we reviewed the research evaluating maternal one-
carbon micronutrient exposures in pregnancy and 
 epigenome-wide DNA methylation in newborns and 
children.
Literature review
We searched the literature (PubMed, Scopus and Web 
of Science databases) in September 2016, to identify 
novel publications describing maternal smoking or 
micronutrient exposures during pregnancy and the 
offspring epigenome. The micronutrients included in 
our search were those identified to play important roles 
in one-carbon metabolism [7]: Folate, choline, betaine, 
methionine, vitamin B2 (riboflavin), B6, B12 (cobala-
min) and homocysteine. Details of the search strategy 
are included in the Supplementary Material.
Epigenetic effects of maternal smoking
Single-site and global methylation associated with 
maternal smoke exposure has been previously evalu-
ated [4]. In that review, the authors highlighted then 
current data suggesting that maternal smoking influ-
ences many different regions of the epigenome, and 
thus emphasized the importance of interrogating asso-
ciations on an epigenome-wide scale. Therefore, we 
focused our search on those studies which have used 
genome-wide methylation arrays to compare meth-
ylation profiles from offspring of women who report-
edly smoked during pregnancy with those of offspring 
whose mothers did not smoke.
Of the 24 studies which met our search criteria (Sup-
plementary Table 1) [5,9–31], publication dates ranged 
from 2011 to 2016. The most common platform which 
has been used is the Illumina Infinium HumanMeth-
ylation450 (450K) followed by the Infinium Human-
Methylation27 (27K) Beadchip, used typically in ear-
lier studies. One study investigated promoter-based 
CpG sites using the Affymetrix Human Promoter 
1.0R array [26] and another investigated whole-genome 
bisulfite sequencing [10]. Sample sizes for the 24 stud-
ies varied from just nine mother–offspring pairs [31] to 
6685 mother–offspring pairs in a meta-analysis across 
13 cohorts [5]. Measures of smoke exposure varied from 
retrospective report, prospective report and objective 
measures of cotinine, with a few studies using a com-
bination of cotinine and self-report [9–10,14–16,23]. The 
most common tissue in which methylation was inves-
tigated was cord blood, followed by peripheral blood at 
later ages, although placenta and lung tissue were also 
investigated [12,20,28], with some studies investigating 
more than one tissue [5,12–13,19,24].
Consistent with this, the most common time point 
at which methylation was measured was at the birth 
of the offspring, while other studies assessed meth-
ylation post conceptually [12], in infancy [10,30], child-
hood [5,10–11,13,18–19,24–25], adolescence/early adult-
hood [9,13,19,24,32] as well as into adulthood [27]. Some 
studies investigated methylation at multiple time 
points  longitudinally [10,13,19,24].
In terms of the methods applied, the majority of 
studies performed EWAS using multivariable lin-
ear regression models with adjustment for potential 
confounding factors (most commonly maternal age, 
offspring sex, socio-economic position, paternal/post-
natal smoking) as well as cell count adjustment, gen-
erally using a reference-based approach [33], and vari-
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Contrasting the effects of intra-uterine smoking & one-carbon micronutrient exposures on offspring DNA methylation    Review
ous technical covariates. Some studies investigated the 
impact of differing exposure assessment, for example, 
comparing cotinine measures with self-reported ques-
tionnaire data [15] or assessing differences between any 
reported smoking in pregnancy versus sustained smok-
ing throughout [5]. Furthermore, some studies were 
able to compare associations between maternal smoke 
exposure during pregnancy with paternal [16–17,24] and 
grandparental smoke exposure [16], as well as postnatal 
smoking effects [5,11,18–19,24–25].
With respect to replication and validation of find-
ings, the majority of studies highlighted overlap 
between their findings and other results from the lit-
erature with a few studies performing formal replica-
tion of top sites in independent datasets [11,15,17,19,21]. In 
addition, validation of differential methylation at CpG 
sites was assessed in a few studies with the use of other 
technologies such as pyrosequencing [10,12,20,26,28–29].
While the majority of these previous studies have 
used an EWAS design, focusing on methylation differ-
ences at individual CpG sites across the genome, some 
studies have taken alternative approaches such as the 
assessment of differentially methylated regions [10,27], 
gene sets [26] and use of Bayesian Mixture Modeling [24] 
for dimensionality reduction. Furthermore, a couple of 
studies have used methods to better capture latent con-
founding and identify additional signals [30,32]. Other 
work developed a methylation prediction score from a 
maternal smoking EWAS to classify maternal smoking 
status in a test dataset [23].
An amassing number of EWAS for maternal smok-
ing has led to the identification of an abundance of 
strong, highly replicated methylation signatures. 
Figure 1 shows a network plot of the top gene regions 
identified in individual studies in relation to maternal 
smoking status. In particular, methylation at CpGs 
in AHRR, CYP1A1, MYO1G, CNTNAP2, GFI1 and 
FRMD4A has been consistently implicated in relation 
to prenatal smoke exposure, most commonly in those 
studies investigating DNA methylation in cord blood. 
However, overlap with some studies assessing meth-
ylation in peripheral blood into childhood and adoles-
cence is evident, implying a lasting effect of maternal 
smoking in pregnancy on offspring DNA methylation 
profiles [5,24].
These gene regions have been implicated in path-
ways related both to regulation of biological processes 
to the exposure (e.g., AHRR and CYP1A1, which 
are both involved in the detoxification of tobacco 
smoke [34]) as well as possible consequential processes 
of the prenatal smoke exposure (e.g., FRMD4A which 
has been associated with nicotine dependence [35] and 
MYO1G, CNTNAP2 and GFI1 which are involved in 
various developmental processes [19,24–25,36–37]).
CpG sites at MYO1G, CYP1A1 and FRMDA4 typi-
cally show an increase in cord-blood methylation in 
relation to maternal smoking whereas AHRR, CNT-
NAP2 and GFI1 show a decrease. This is reflective 
of changes across the whole genome, where smoking 
during pregnancy has been associated approximately 
equally with hyper and hypomethylation [5]. The 
average percent change in methylation at these sites 
has shown to be small, ranging from -8 to 7% in the 
study by Markunas et al. [21]. Further annotation of the 
CpG sites in these gene regions illustrated a significant 
enrichment for CpG shores/islands and intronic/inter-
genic locations [21].
In terms of the impact of methylation changes on 
gene expression, this has been most consistently inves-
tigated in relation to AHRR. Cg05575921, the site 
most strongly associated with both maternal smoke 
exposure and own smoking [3] has been shown to be 
inversely associated with AHRR expression in different 
tissues [38]. Upregulation of AHRR expression acts as 
a negative regulator of the aryl-hydrocarbon receptor 
(AhR) pathway, and in turn suppresses CYP1A1 tran-
scription, another gene strongly implicated in relation 
to maternal smoking. Consistent with this, smoking 
has an opposite impact on DNA methylation at sites 
in CYP1A1 (hypermethylation) to AHRR (hypometh-
ylation) in cord blood, which is anticipated given the 
opposing function of these genes in the AhR pathway. 
Interestingly, however, CYP1A1 has been found to be 
hypomethylated in placenta, which is correlated with 
increased expression in this tissue [39].
The proposed biological implications of these gene 
expression changes are also conflicting, with some 
studies suggesting that the inhibition of the AhR path-
way may compromise the body’s capacity to metabo-
lize harmful environmental chemicals among those 
exposed to smoke [3], whereas others suggest that 
the feedback response of AHRR in relation to smoke 
exposure is actually adaptive because it inhibits the 
released of carcinogenic metabolites produced by the 
AhR pathway [40], which is in part corroborated by 
the role of AHRR as a putative tumor suppressor [41]. 
The impact of smoke-induced methylation changes in 
relation to cancer outcomes are starting to be evalu-
ated [42] and may have potential relevance in this con-
text for implicating methylation in the causal pathway 
between maternal smoke exposure and increased risk 
of childhood cancers [43]. Furthermore, the down-
stream consequences of methylation changes at other 
CpG sites associated with maternal smoking in relation 
to some perinatal and childhood outcomes have also 
been investigated in a mediation context [10,20,23,28–29] 
although the causal relevance of these findings require 
further evaluation (see section ‘Mediation’).
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Figure 1. Network visualization of individual studies investigating maternal smoking in relation to offspring DNA methylation. 
Squares represent individual studies; numbers represent related PubMed IDs; circles represent gene regions; text represents 
annotated gene names; arrows represent the links between the studies and the gene regions, in other words, highlighting studies in 
which CpG sites have been identified in these gene regions at either Bonferroni significance or with replication/validation attempts; 
the size of the circle is proportional to the number of independent studies in which the gene regions have been identified. N.B. this 
network plot does not include the recent epigenome-wide association studies meta-analysis for maternal smoking (PMID 27040690).
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Epigenetic effects of maternal one-carbon 
micronutrients
Research on the influence of micronutrients on DNA 
methylation falls within a larger field of nutritional 
epigenomics. Maternal nutrition impacts fetal devel-
opment and there is some evidence of modifications 
to the newborn epigenome related to maternal micro-
nutrient exposures in pregnancy. However, despite a 
topic of interest for many years, the data demonstrat-
ing newborn epigenetic effects of maternal micronu-
trients during pregnancy is substantially less than the 
evidence for the effects of maternal smoking on the 
offspring epigenome.
Of the seven studies which met our search crite-
ria (Supplementary Table 2) [44–50], publication dates 
ranged from 2012 to 2016. The most common plat-
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form which has been used is the 27K (four studies) 
followed by the 450K (three studies). All seven micro-
nutrient studies focused on maternal folate during 
pregnancy. Although one study [48] evaluated other 
nutrients such as betaine, choline and other nutrients 
involved in one-carbon metabolism, the strongest 
effects on offspring methylation were observed for 
maternal folate levels in pregnancy. Sample sizes for 
the seven studies ranged from 18 neonates of mothers 
enrolled in a clinical trial [46] to nearly 2000 mother-
offspring pairs in a meta-analysis of two independent 
European cohorts [48]. Measures of folate exposure 
included measurements from maternal serum, plasma 
or blood samples as well as maternal report of folic acid 
supplementation. All studies measured methylation 
in cord blood samples, while one study also measured 
methylation in peripheral blood in infancy [45,49]. Only 
one study [49] evaluated methylation at multiple time 
points (birth and 9 months) and observed a stronger 
effect at the later time point.
The statistical methods applied in the micronutri-
ent studies included the epigenome-wide association 
analysis using multivariable linear regression models 
with adjustment for potential confounding factors, but 
many studies were underpowered for this approach. 
The earliest publication used Illumina’s methylation 
module for data analysis of 27K data [49], whereas other 
studies using clustering approaches such as principal 
components analysis [44] or hierarchical clustering [46]. 
Studies published in 2015 and 2016 accounted for cell 
type as a covariate in statistical models whereas earlier 
studies did not necessarily consider cell type hetero-
geneity. One study [45] measured the MTHFR geno-
type and incorporated a Mendelian randomization 
approach to data analysis.
Regarding replication, only one study evaluated 
more than one population, in this case with meta-
analysis rather than independent replication analy-
sis [48]. Other studies evaluated one study population. 
Figure 2 shows the comparison of results across stud-
ies. Not surprisingly, there is minimal replication of 
findings across the micronutrient studies. This likely 
reflects many things: the differences in sample type, 
study design, study population, microarray coverage 
and statistical modeling.
Comparison of EWAS findings
Stronger statistical significance (in terms of the number 
of EWAS-significant sites) was observed for the mater-
nal smoking studies compared with the micronutrient 
studies, and methylation sites were more consistently 
replicated between studies. Comparing the largest 
studies for both maternal smoking and maternal folate 
to date [5,48], the manuscript evaluating maternal folate 
in pregnancy included only two cohorts with an over-
all sample size of 1988 newborns, whereas the paper 
evaluating maternal smoking during pregnancy evalu-
ated 13 independent cohorts with an overall sample 
size of 6685 newborns. The smoking study reported 
6073 CpGs reaching false discovery rate (FDR)-cor-
rected statistical significance whereas the folate study 
observed 443 FDR significant CpGs.
Although there is a substantial difference in sample 
size, maternal smoking appears to have a more far-
reaching impact on the methylome in terms of the 
number of epigenome-wide significant sites which have 
been consistently replicated between studies (Figures 1 
& 2). It is possible that folate impacts just a few impor-
tant genes or pathways, whereas smoking has more 
multifaceted biological implications reflected in the 
number of pathways and genes identified. However, 
outside of considering true impact of the compared 
exposures on the epigenome, there are several statistical 
factors that may explain the discrepancy between the 
robustness of EWAS hits and minimal overlap of find-
ings for maternal micronutrient exposures  compared 
with the maternal smoking publications.
Statistical methodology
The statistical challenges of EWAS have been dis-
cussed in detail elsewhere [51–54], and are also relevant 
for the investigation of both maternal smoking and 
micronutrient exposure. For example, low statistical 
power, publication bias, noise in the exposure variable, 
as well as various confounding factors threaten the 
detection of biological signals of interest and the ability 
to infer causality from to the epigenomic modifications 
associated with maternal smoke and  micronutrient 
 exposures.
Methods for improving the robustness of EWAS 
findings have been implemented in some of these exist-
ing studies, predominantly in relation to maternal 
smoking, although areas for improvement include: fur-
ther investigation into the magnitude and persistence 
of effects on methylation; improving power for detect-
ing methylation signals; careful exposure assessment; 
accounting for cell type heterogeneity; and assessing 
causality with respect to both the maternal exposure 
and in relation to the observed methylation changes 
in mediating downstream outcomes which have been 
implicated.
Persistence of effects
Persistence in a methylation signal over time can pro-
vide insight into epigenetic effects of early life envi-
ronmental exposures. For example, prospective studies 
investigating associations between maternal smoking 
in pregnancy and peripheral blood methylation in off-
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Figure 2. Network visualization of individual studies investigating maternal folate in relation to offspring DNA methylation. Squares 
represent individual studies; numbers represent related PubMed IDs; circles represent gene regions; text represents annotated gene 
names; arrows represent the links between the studies and the gene regions, in other words, highlighting studies in which CpG sites 
have been identified in these gene regions at either Bonferroni significance or with replication/validation attempts; the size of the 
circle is proportional to the number of independent studies in which the gene regions have been identified.
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spring during childhood and adolescence [5,24] have 
identified strong similarity with smoking-associated 
methylation in newborns, implying a lasting effect of 
maternal smoking in pregnancy on offspring DNA 
methylation profiles at these sites. However, one paper 
from the micronutrients review evaluated more than 
one time point in an individual which found a stron-
ger effect of exposure slightly later in life rather than 
early and persistent effects [49]. In contrast, an inde-
pendent study published subsequent to conducting our 
literature search measured methylation in cord blood 
at birth, whole blood at age 7, and substance use in 
adolescence at ages 14–18 and found that methyla-
tion differences at birth predicted earlier initiation and 
longer term substance abuse in adolescent life better 
than methylation differences at age 7 [55]. Further-
10.2217/epi-2016-0135www.futuremedicine.comfuture science group
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more, these methylation differences were suggested 
to partially mediate the effect of prenatal maternal 
smoke exposure on adolescent substance use (see sec-
tion ‘Mediation’).
These contrasting findings suggest that additional 
research is warranted to clearly differentiate the inde-
pendent and combined effects of environmental expo-
sures over time on later life DNA methylation and 
health end points. It is also likely that these patterns 
differ across assessed environmental exposures.
Assessing power for detecting methylation 
signals
Figures 1 & 2 highlight some of the isolated maternal 
smoking and one-carbon micronutrient studies where 
findings have not been consistently replicated. These 
are typically those studies with small sample size where 
methylation differences have been validated with the 
use of pyrosequencing, but without replication in an 
independent study population. While it is possible 
that these signals represent false positive findings, the 
results of a larger meta-analysis not included in this fig-
ure and described below [48] identified some sites which 
were not previously replicated in the individual studies 
from Figure 1. This indicates that some of these sites, 
while not showing replication in previous studies, may 
indeed be true positives. Another potential explanation 
for sites which have not been replicated is that these 
methylation signals are an artifact of methylation plat-
form (27K vs 450K), or alternatively the result of meth-
ylation profiling in different tissues (e.g., placenta) or 
populations (e.g., ethnic groups), although these stud-
ies were performed in samples from individuals of pre-
dominantly European ancestry. These factors may also 
explain the lack of replication of CpG sites in relation 
to maternal micronutrient status in Figure 2.
To improve statistical power which will be more 
equipped to account for noise in the exposure, larger 
sample sizes are needed in studies as well as replica-
tion. Meta-analysis is the most conventional means of 
improving power in GWAS, which has recently been 
adopted by the epigenetics field, for example by the 
Pregnancy and Child Epigenomics (PACE) consor-
tium, following models from GWAS consortia such 
as Cohorts for Heart and Aging Research in Genomic 
Epidemiology (CHARGE) and Early Growth  Genetics 
(EGG).
The PACE consortium has meta-analyzed, across 13 
cohorts and 6685 individuals, the association between 
maternal smoking in pregnancy and DNA meth-
ylation in newborn cord blood [5]. In this study, over 
6000 CpG sites were found to be differentially meth-
ylated, including sites previously identified in smaller 
EWAS studies (Figure 1) as well as many novel loci. 
Furthermore, evidence for persistence of methylation 
marks at older ages in the offspring exposed to prenatal 
smoke exposure has been corroborated in this EWAS 
meta-analysis, where many of the sites identified in 
cord blood showed differential methylation in five 
cohorts which also had methylation data available in 
older children, with 73% of sites showing a consistent 
direction of effect and 148 CpGs identified with FDR 
 significance at replication level [5].
Furthermore, this meta-analysis identified differen-
tial methylation in several genes which were also found 
to be enriched in development and disease pathways, 
including genes relevant to outcomes associated with 
smoke exposure such as orofacial clefts, asthma and 
certain cancers. The study also evaluated the relation-
ship between significant CpGs and gene expression 
in two independent study populations. However, the 
study did not investigate methylation in any other tis-
sues, which are less accessible in many of the larger 
cohort studies, and did not formally investigate any of 
the downstream consequences of the observed methyl-
ation changes in terms of phenotypic differences in the 
offspring, as was attempted in some of the individual 
studies [10,17,20,23,28–29].
The meta-analysis approach typically requires 
harmonization of exposure metrics and covari-
ates included in cohort-specific statistical models. 
For many of the maternal micronutrient studies 
(Supplementary Table 2), we observed substantial 
variability in these features. Thus, a meta-analysis or 
pooled analysis approach may be most successful if col-
laborations discuss design strategies before implement-
ing procedures (e.g., synthesizing methods for assess-
ing micronutrients, DNA methylation pre-processing 
and quality control, time points of sample collection, 
etc.), while maintaining unique study population 
characteristics.
Exposure assessment
A major challenge in epidemiological studies is to 
ensure adequate exposure assessment. This includes not 
only measuring exposure accurately but also account-
ing for the timing and dose of the exposure. There are 
several ways in which the smoking and micronutri-
ent exposures contrasted here differ in how they are 
assessed and what biases may impact results. For most 
study populations, there is stigma related to smoking 
during pregnancy, which increases the likelihood of 
underreporting true smoking exposure by the mother. 
To address this, some studies use cotinine, a biomarker 
for smoking, to objectively capture exposure at a single 
point in time. Although a single measure of cotinine at 
one point in pregnancy will not adequately capture all 
exposure throughout pregnancy, it can provide insight 
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into how accurately the self-reported data correlates to 
biomarkers of exposure.
For micronutrient exposures during pregnancy, 
there may be aspects of both under and over reporting 
of exposure, depending on dietary information col-
lected, supplement use and the presence of biomarker 
metrics. Given the variability in how reports may be 
biased and generally noisy, it may be even more crucial 
to obtain biological specimens from the mother during 
pregnancy such as plasma, serum and blood, and to 
obtain the most stable biomarkers of exposure such as 
red blood cell folate rather than serum or plasma-based 
measurements. Validation of micronutrient exposure 
may also be more complicated than it is for smoking 
as there are multiple routes of exposure (diet, supple-
ment use, co-exposures that influence metabolism) 
and multiple ways of measuring exposure (biomarkers, 
food frequency questionnaire data, study-specific ques-
tionnaires). As such, it is crucial for nutritionists to be 
involved in this complicated exposure assessment in 
addition to the standard molecular epidemiology and 
statistical team.
Differences in the extent and robustness of meth-
ylation signals may reflect the route of exposure. For 
example, the associations found between maternal 
cotinine levels, an objective biomarker of smoking and 
DNA methylation in newborns implies a dose-depen-
dent effect of maternal smoking in pregnancy [15]. This 
dose-response reflects the direct inhalation of tobacco 
smoke, whereas micronutrient exposures are primar-
ily dietary through food or supplements. It is possible 
the interaction with other foods, the consistency of 
intake, or the role of metabolism are involved in the 
ultimate dose of micronutrient exposure within the 
body. In many ways the micronutrient exposures are 
substantially noisier and with greater variability within 
a person at a given point in time, over time and within 
a study population. This variability will reduce power 
to detect statistically significant associations after 
 applying correction for multiple testing.
Another consideration in exposure assessment is 
timing of measurement. With respect to the litera-
ture on maternal smoking EWAS, several studies have 
highlighted the importance of sustained smoking dur-
ing pregnancy [5,16,24], rather than smoking around the 
periconceptional period, which has been found to be 
independent of smoking intensity [16]. This is interest-
ing given a priori knowledge that epigenetic profiles are 
typically established in early development and propa-
gated during embryogenesis [56]. Rather, it suggests 
that cumulative exposure to environmental stimuli in 
utero might have a greater impact on the developing 
offspring than restricted exposure windows. We did 
not find many longitudinal studies evaluating expo-
sure at multiple windows in this review, but recom-
mend this for future research. This is particularly of 
interest for epigenomic studies of maternal micronutri-
ents, given the preferential timing of supplementation 
during the periconceptional period [57].
Another notable weakness in both the smoking and 
micronutrient studies published to date is the under-
representation of minority study populations, who may 
have variable exposure and related characteristics com-
pared with study populations primarily of European 
ancestry (Supplementary Tables 1 & 2).
Given robustness of methylation marks in relation 
to an exposure of interest, one strategy is to use epigen-
etic signatures to estimate the existence and magnitude 
of exposure by serving as prediction markers. A recent 
study developed a methylation prediction score from a 
maternal smoking EWAS to classify maternal smoking 
status in an independent dataset [23]. Such a score may 
serve as an archive of historical exposure, for example, 
when no smoking history has been collected in a study, 
and as a means of assessing exposure misclassifica-
tion, for example, to assess misreporting of smoking 
behavior during pregnancy or to substitute for poorly 
 measured dietary data.
Assessing causality
Findings from EWAS of maternal exposures such 
as smoking and micronutrient are of particular util-
ity for investigating hypotheses on the proposed epi-
genetic processes underpinning intrauterine effects 
on offspring health and development [58]. However, 
it is important to realize that methylation signatures 
are essentially phenotypic, and are therefore sub-
ject to the same potential problems of confounding, 
reverse causation and bias which afflict observational 
 epidemiology [54,59].
While, in the context of prenatal exposures, reverse 
causation is not a major concern given it is unlikely 
that the offspring’s methylome will directly influence 
the maternal phenotype, the potential for bias and con-
founding threaten the detection of true causal effects. 
Bias has been exemplified with the poor replication 
of some methylation sites between different EWAS 
(Figures 1 & 2), given the extent of multiple testing and 
increasing probability of false positive findings in this 
context. As mentioned, key strategies to reducing the 
likelihood of such bias are through increasing power in 
individual studies and through meta-analysis.
Furthermore, it is possible that the associations 
observed between prenatal exposures and offspring 
DNA methylation are subject to confounding, due 
to the potential presence of factors which modify 
methylation profiles and are also associated with the 
 exposures.
10.2217/epi-2016-0135www.futuremedicine.comfuture science group
Contrasting the effects of intra-uterine smoking & one-carbon micronutrient exposures on offspring DNA methylation    Review
Cell type heterogeneity
One major factor thought to lead to spurious results 
in EWAS is ‘confounding’ by cell-type heterogeneity. 
Although this is not confounding in the strict sense, 
since cell type proportions of the samples being pro-
filed for methylation are unlikely to influence the 
maternal exposure, if cellular differences are found 
to underlie the observed methylation changes this has 
consequences in terms of the interpretability of the 
EWAS findings [60] or in CpG-specific findings [61,62]. 
It is therefore important to correct for cell type in 
the setting of maternal exposures such as smoking 
and micronutrients, which have been found to influ-
ence cell type proportions, with the use of reference-
based [33,63] or reference-free approaches [64]. In the 
meta-analysis of maternal smoking by Joubert et al., a 
method of cell type correction based on an adult ref-
erence panel [33] showed that 78% of sites identified 
in the main model retained EWAS-significance in  cell 
type-adjusted models.
Genetic confounding
Interindividual variation in methylation can be a conse-
quence of DNA sequence polymorphisms that result in 
methylation quantitative trait loci (meQTLs) [65,66]. As 
such, the role of genetic transmission in explaining an 
association between a maternal exposure and offspring 
methylation should ideally be considered when trying 
to assert causal intra-uterine effects. One simple means 
of testing this is by ensuring no single nucleotide poly-
morphisms underlie the methylation probes of inter-
est [67], although long-ranging cis- and trans- effects can 
explain a great proportion of variability in DNA meth-
ylation, indicating the importance of integrating both 
genetic and epigenetic architecture to delineate effects.
Residual confounding
The most commonplace method for evaluating and 
minimizing the impact of confounding in EWAS is 
with the inclusion of covariates associated with the 
exposure. In the case of maternal exposures, these 
potential confounders are most commonly maternal 
age, parity and socio-economic status. From the EWAS 
investigated here (Supplementary Tables 1 & 2), various 
adjustments for potential confounding factors, on the 
whole, did not substantially attenuate results. However, 
the ability to adequately account for potential con-
founders relies on the assumption that they have been 
identified and measured with little or no error. In the 
absence of full or detailed information about potential 
confounders, a matrix decomposition method (such as 
surrogate variable analysis) may be used to account for 
unmeasured and residual confounding in an agnostic 
manner [68].
Causal inference methods
As well as these conventional strategies to minimize the 
impact of confounding in EWAS studies, some alter-
native strategies adapted from observational epidemio-
logical studies may also be used, some of which have 
been considered in the context of maternal smoking 
and micronutrient intake and offspring methylation.
The strongest evidence relating maternal exposures 
to offspring methylation derive from intervention 
studies, such as those where strong external nutritional 
factors influence the population under study largely 
at random and therefore are not typically associated 
with confounding factors [69,70]. The ‘gold standard’ 
for causal inference is the randomized controlled 
trial (RCT), for example, with the randomization of 
women to different interventions in pregnancy. Such 
an approach was used in one study [49], where meth-
ylation differences were found among the offspring of 
Gambian women who were enrolled in a placebo-con-
trolled RCT for preconceptional micronutrient supple-
mentation (Supplementary Table 2). Nonetheless, the 
specificity of the micronutrient exposure in this setting 
was not confirmed and few trials of individual micro-
nutrients in pregnancy have been reported in relation 
to methylation changes. In addition, although the gold 
standard, RCTs are sometimes impossible or unethi-
cal to implement, for example, in the context of ran-
domizing women to folic acid supplementation in early 
pregnancy (for which there are known adverse conse-
quences of folate deficiency on offspring development).
In the absence of RCTs or other intervention 
designs, various methods have been developed to min-
imize problems afflicting observational epidemiology 
and to strengthen causal inference [71], which may be 
relevant to the epigenetic community and which have 
already been applied, predominantly in the context of 
maternal smoke exposure, but increasingly in relation 
to micronutrient supplementation.
We have already mentioned the utility of examining 
the strength of association, dose-response and persis-
tence of methylation in response to the maternal expo-
sure. It is also of interest to investigate the specificity of 
an association. For example, with respect to maternal 
smoking the finding that methylation in the AHRR 
provides good evidence against confounding given that 
this gene is directly implicated in the detoxification of 
tobacco smoke, therefore providing specificity of func-
tion. Similarly, for maternal folate some of the CpGs 
identified in the largest EWAS to date were found to 
be directly related to folate biology [48].
Nonetheless, the multitude of chemicals in ciga-
rette smoke and complexity of one-carbon metabolism 
means that these exposures may impact multiple bio-
logical pathways, limiting the specificity of the associa-
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tion between this exposure and methylation change in 
other gene regions. For sites where biological plausi-
bility is less well known, other methods may be used 
to establish specificity of the association between the 
maternal exposure and offspring methylation. A nega-
tive control approach is one that utilizes an additional 
exposure or outcome that would be liable to the same 
sources of confounding, but for which causal associa-
tions cannot be plausibly ascribed [72,73]. Any evidence 
of an association over and above that observed in the 
negative control is indicative of a causal effect.
A negative control design primarily used for explor-
ing the extent to which associations of intra-uterine 
exposure might be causally related to offspring out-
comes is the parental comparison approach. Such a 
design has previously been used to establish the causal 
effect of maternal smoking (and not paternal smok-
ing) on offspring methylation [16–17,24]. In the context 
of evaluating the long-term effect of prenatal smoke 
exposure on DNA methylation, maternal smoking 
after pregnancy may be used as a negative control 
which would not be expected to have the same effect as 
smoking during pregnancy if the mechanism of influ-
ence is through the intra-uterine environment. In par-
ticular, longitudinal studies with repeated measures of 
smoke exposure both pre- and postnatally are useful 
at unpicking various life course effects and defining 
‘critical periods’ for the establishment of methylation 
marks [24].
Mendelian randomization
Mendelian randomization is a method that uses genetic 
variants robustly associated with modifiable exposures 
to infer causality [74,75]. As genetic variants can be 
assumed to be randomly assigned [76], this approach 
is in principle analogous to an RCT, where study par-
ticipants are randomly allocated to one or another 
treatment, avoiding potential confounding between 
 treatment and outcome.
Mendelian randomization may be used to provide 
unique insights into the causal nature of intra-uterine 
exposures, where maternal genotype is taken to be a 
proxy for environmentally modifiable exposures in 
pregnancy that influence the intra-uterine environ-
ment [77]. For example, genetic variation in MTHFR 
is associated with methylenetetrahydrofolate reduc-
tase activity and so with circulating folate levels. 
As such, genetic variation at MTHFR ‘mimics’ the 
effect of maternal folate supplementation in an RCT 
(Figure 3). In the context of offspring DNA methyla-
tion, the MTHFR genotype has been used in a Men-
delian randomization context to investigate the causal 
effect of maternal red blood cell folate on genome-wide 
 methylation in infant cord blood [45].
Mediation
Given evidence for causal associations between mater-
nal smoking and micronutrient exposures in preg-
nancy and methylation changes in the offspring, it 
is important to consider whether induced changes 
are also associated with perinatal and offspring out-
comes attributed to these exposures, and further work 
is required which may link methylation variation to 
health and development [58].
With respect to maternal smoking, there is increas-
ing attention on performing downstream analyses, to 
link methylation differences with transcriptional dif-
ferences or changes in gene expression [5,10–11,26,28–29]. 
Furthermore, functional enrichment and pathway anal-
yses have been performed to link the observed methyla-
tion differences with biological pathways, highlighting 
observed enrichment in pathways and processes criti-
cal to development and conditions that can be caused 
by maternal smoking such as orofacial clefts and 
asthma [5]. Furthermore, some studies have investigated 
associations between differential methylation and spe-
cific offspring outcomes associated with prenatal smoke 
exposure, including infant weight [23,28–29], gestational 
age [20], atopic dermatitis [29] and lung function [10]. 
Similarly, because of the relevance to early life health 
outcomes such as neural tube defects, some studies such 
as Price et al. [78] have specifically evaluated the rela-
tionship between folate levels and neural tube defects to 
consider mediating effects of methylation.
However, despite these findings it remains to be seen 
whether the small observed changes in DNA methyla-
tion are biologically (e.g., impacting transcription) or 
clinically relevant and whether the association with 
offspring phenotypes are truly causal. In particular, 
whether DNA methylation is a true mediating mecha-
nism of these associations or simply a refined exposure 
indicator requires further exploration by extending 
causal inference.
Epidemiological studies have tended to profile 
methylation signatures from easily accessible sources 
of DNA, such as cord or whole blood. However, how 
likely it is that DNA methylation in blood mediates 
the effect of the in utero exposure on a developmen-
tal trait, and whether blood cell methylation is rep-
resentative of the epigenetic state of a target tissue, 
remains unclear [79]. Tissue specificity therefore limits 
the assessment of functional consequences of methyla-
tion changes. Attempts should be made to investigate 
concordance of methylation signatures between tissues 
in relation to a maternal exposure, which can provide 
more insight into systemic effects, and to investigate 
mediation of methylation in target tissues more closely 
linked with the offspring outcomes of interest rather 
than peripheral tissues [12].
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Figure 3. Comparison of design of a Mendelian randomization study and randomized controlled trial in the 
context of establishing a causal effect of maternal folate on DNA methylation.
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Furthermore, limitations of observational epidemi-
ology (specifically measurement error, confounding 
and reverse cause) can also afflict conventional media-
tion approaches and may lead to incorrect conclusions 
regarding causal effects in the context of methylation 
change [80]. Solutions to these problems include the 
use of experimental designs [10] as well as Mendelian 
randomization [81] which may be used to establish the 
causal impact of the methylation change on an offspring 
outcome, independent of the exposure of  interest.
A study published subsequent to conducting our lit-
erature search investigated the role of DNA methyla-
tion in mediating the known causal effect of maternal 
smoking on offspring birthweight using a Mendelian 
randomization approach [82]. This study was conducted 
using methylation data from placental tissue, an organ 
that plays a key role in fetal growth and development, 
and taking meQTLs robustly associated with changes 
in methylation at the sites of interest to establish causal 
effects. Results of the study suggested a causal effect 
between decreases in placental methylation at a CpG site 
between LINC00086 and LEKR1 and lower birthweight 
in the offspring (Figure 4). However, the authors of the 
study state that these results should be taken with caution 
because of potential pleiotropic effects of the meQTLs 
on birthweight which cannot be completely ruled out.
Future perspective
Implications of findings
In this review, we describe existing literature for two 
maternal exposures (maternal smoking and maternal 
micronutrient exposure) in pregnancy and the off-
spring epigenome. Restricting our review to EWAS 
only using popular technologies measuring CpG-spe-
cific methylation across the genome, we identified 24 
relevant maternal smoking studies and seven relevant 
micronutrient studies. In addition to differences in the 
underlying biology involved in how these two impact 
the developing epigenome, there are several method-
ological considerations to consider, including sample 
size, combined analyses using meta-analysis, avail-
ability of data, challenges to exposure measurement, 
statistical approaches and assessment of persistent 
effects. We found the literature describing the influ-
ence of maternal smoking in pregnancy on the off-
spring epigenome to be substantially more populated 
with regards to the above considerations compared 
with the micronutrient literature. This may in part be 
driven by the availability of data across many cohorts 
and the recent consortium-based efforts for smoking 
that represent a proof of principle to guide efforts on 
other environmental exposures. Notably, similar col-
laborative efforts can be useful to evaluate more ‘noisy’ 
exposures such as micronutrients given the increase in 
statistical power and ability to evaluate heterogeneity 
of effects across studies.
It is possible that maternal smoking during preg-
nancy has a greater true biological impact on the off-
spring methylome – impacting more sites and more 
genes – compared with maternal micronutrient expo-
sures. This makes sense in many ways due to the numer-
ous health effects associated with prenatal and active 
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Figure 4. Mendelian randomization analysis to establish the causal effect of maternal smoking-associated DNA 
methylation change in relation to offspring birthweight, using genetic variants robustly associated with DNA 
methylation (meQTLs).meQTL: Methylation quantitative trait loci.
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smoking. In contrast, micronutrients such as folate may 
represent true biological differences that impact the 
methylome, but that involve fewer processes, pathways 
and implicated genes. Further research is warranted to 
more clearly understand these differences and whether 
they can be attributed to statistical factors, noise in the 
data or true biological differences.
Future directions
With respect to research on maternal micronutrients 
and offspring methylation, there is a need for more 
large-scale research in this area, specifically with regard 
to investigating the independent and combined effects 
of micronutrients other than folate. To understand 
the broader reaching impact of micronutrients on the 
human methylome, efforts to further replicate find-
ings using independent epidemiological study popula-
tions is needed. Publications demonstrating the lack 
of replication are also important to avoid unnecessary 
repeated efforts, although this is a tricky argument due 
to population and methodological differences across 
studies.
Ongoing efforts with meta-analysis or pooled analy-
ses is very important. This not only increases statisti-
cal power to detect effects but can offer many insights 
into how exposure and effects vary across independent 
study populations. In order for this to be successful in 
relation to maternal micronutrients, harmonization of 
exposures in different studies first needs to be estab-
lished. Furthermore, metrics used in GWAS such as 
p-values for heterogeneity can be evaluated in EWAS 
but may also need further development from statisti-
cians to determine which heterogeneity metrics are 
most useful.
Most of the EWAS presented here used typical ‘fre-
quentist’ or parametric approaches to data analysis. 
However, nonparametric approaches such as the use 
of Bayesian models are also possible and may pro-
vide alternative ways to analyze data with less depen-
dency on sample size. Other less traditional statistical 
approaches should also be considered for these com-
plex datasets, particularly when multiple exposures are 
addressed. Furthermore, consideration should be given 
to the evaluation of differentially methylated regions 
and gene sets rather than single CpG sites in order to 
reduce the dimensionality of the data and multiple 
testing burden, as well as to identify more biologically 
relevant units of methylation change.
The Illumina Infinium HumanMethylationEPIC 
array is now superseding the HumanMethylation450 
Beadchip, targeting 850,000 CpG sites across the 
genome [83]. This array covers >90% of CpGs on the 
450K array, with the addition of CpGs located in 
enhancer regions. It will be of interest to investigate 
maternal smoking and micronutrients in relation to 
methylation on this array, given the upsurge in findings 
after progressing from the 27K and 450K. Further-
more, we must realize the value of studies investigating 
the use of whole-genome bisulfite sequencing in this 
context [10], and RNA sequence data for  integrating 
methylation with gene expression.
Most large-scale epigenetic studies in humans mea-
sure methylation in blood. Cross-tissue analyses should 
also continue as this field develops, and the extent to 
which methylation signals persist into later childhood 
and adulthood, which may provide additional insight 
into widespread and long-term effects of early life 
environmental exposures on the methylation. Efforts 
in the context of a consortium-based approaches such 
as PACE will be valuable for interpreting widespread 
exposure effects and set a model for evaluating long-
term epigenetic effects of other early life environmental 
exposures.
The downstream health implications of persistent 
methylation change in response to intra-uterine smoke 
exposure also require further evaluation. As previous 
studies have alluded to, persistent changes in DNA 
methylation might mediate at least some of the associa-
tions between smoke exposure in pregnancy and later 
life health outcomes. It is possible that alterations in 
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Executive summary
Maternal smoking & the offspring epigenome
•	 Maternal smoke exposure has a profound effect on epigenome-wide methylation changes in the offspring.
•	 Alterations in DNA methylation are one possible mechanism mediating the harmful effects of smoke exposure.
•	 Epigenome-wide approaches for investigating prenatal smoke exposure have identified an increasing number 
of methylation signatures in biologically relevant regions of the genome.
•	 An amassing number of epigenome-wide association studies (EWAS) for maternal smoking has led to the 
identification of a plethora of strong, highly replicated methylation signatures.
Maternal micronutrient intake & the offspring epigenome
•	 Micronutrients particularly relevant to epigenetic mechanisms include those involved in the one-carbon 
metabolism pathway, including folate, choline, betaine and other B vitamins, which provide methyl groups for 
a range of biochemical reactions including methylation of DNA.
•	 Differences in genome-wide DNA methylation in newborns have been evaluated in relation to maternal 
folate and other micronutrient exposures in candidate gene methylation studies, although their evaluation in 
genome-wide association DNA methylation studies is lagging behind.
•	 A comparison of effects in nourished compared with undernourished populations remains to be fully elucidated, as 
well as the extent to which single micronutrients or combinations of micronutrients impact methylation differences.
Comparison of EWAS findings
•	 Stronger statistical significance (in terms of the number of EWAS-significant sites) was observed for the 
maternal smoking studies compared with the micronutrient studies, and methylation sites were more 
consistently replicated between studies.
Statistical methodologies
•	 Low statistical power, publication bias, noise in the exposure variable, as well as various confounding factors 
threaten the detection of biological signals of interest and the ability to infer causality from associations 
identified in relation to maternal smoke and micronutrient exposure.
•	 Methods for improving the robustness of EWAS findings have been implemented in some of these reviewed 
studies, predominantly in relation to maternal smoking, although we highlight areas for improvement: 
investigating the magnitude and persistence of effects on methylation, improving power for detecting 
methylation signals, careful exposure assessment, deeper understanding of cell type heterogeneity, assessing 
causality with respect to both the maternal exposure and in relation to the observed methylation changes in 
mediating later health outcomes.
•	 We found the literature describing the influence of maternal smoking in pregnancy on the offspring DNA 
methylation to be substantially more advanced with regard to use of the above methods compared with the 
micronutrient literature.
Other prenatal influences & the offspring epigenome
•	 The impact of other intrauterine exposures on the epigenome was outside the scope of this review but 
include: other micronutrients (fatty acids, vitamins and minerals), maternal stress, endocrine disruptors and 
heavy metals, which have been reviewed in detail elsewhere in this Epigenomics issue.
•	 In addition, this review did not specifically address the impact of paternal exposures on the offspring 
epigenome, which have been implicated in relation to early life programming, and for which some 
methylation changes have been observed.
Future perspective
•	 Additional assessment of micronutrients should be evaluated in larger sample sizes and combined efforts to 
more adequately compare with folate findings.
•	 Collaborative research efforts such as meta-analysis across multiple cohorts are important to address 
hypotheses with adequate statistical power.
•	 Thorough consideration should be given to confounding in EWAS studies by factors such as socio-economic 
position, dietary intake, stress and ethnicity.
•	 Further statistical and causal inference analyses are required to fully elucidate the epigenetic effects of both 
maternal smoking and micronutrients, given the recent technological developments in methylation arrays.
•	 Cross-tissue analyses are needed to evaluate heterogeneity of effects across sample type and cell type-specific 
effects should be investigated to extract biological relevance of methylation changes.
•	 More research into the widespread (cross-tissue) and long-term effect of these exposures on offspring 
methylation is warranted.
•	 Further investigation of the downstream health implications of methylation change in response to intra-
uterine exposure also requires further evaluation.
•	 Ongoing efforts in animal studies should continue with the human studies for comparison and validation purposes.
•	 Combined exposures or ‘mixtures’ of exposures should be considered in the context of well-powered and well-
described mature datasets.
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genes uncovered by this research may be involved in 
the mechanisms by which these exposures have lasting 
effects on children’s health, and by better understand-
ing these mechanisms we can develop more ways of 
 intervening to correct any long-term detrimental effects.
Research in animal models should also continue and 
be compared with the results of human studies. Col-
laborations between animal and human researchers 
will also be helpful in addition to the larger consor-
tium efforts for human studies, in order to test puta-
tive causal candidates and proposed mechanisms in 
 different contexts.
What was not presented in this review was the 
potential combined effect of maternal smoking and 
micronutrient exposure in pregnancy. Although we did 
not specifically search for this in our literature review, 
no studies we identified evaluated a combined effect 
of maternal smoking and micronutrient exposure. It 
is possible that these exposures could have potentially 
opposing impact on the epigenome given the variable 
effects on offspring phenotype. However, we did not 
observe overlap in the implicated genes and pathways 
from these studies so it may also be plausible that they 
act independently on the developing epigenome. The 
use of analytic tools such as meta-analysis may shed 
more light on how the combined effect of these expo-
sures impact epigenome-wide methylation and health 
end points over time in exposed offspring. Such tools 
may also be used to detect heterogeneity and bias in 
contributing studies. Further research (particularly 
longitudinal periconceptional/perinatal studies) may 
be able to more clearly elucidate how this combina-
tion, and other relevant combinations of exposures or 
‘mixtures’ of environmental exposures, cumulatively 
impact the developing epigenome.
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